S100B and schizophrenia: Moreover, a large number of clinical studies have demonstrated that the S100B levels are elevated in the CSF and/or serum of patients with various neuropsychiatric diseases, including schizophrenia [41, 42], bipolar disorder [43], ischemic stroke [20], multiple sclerosis [44] and AD [22, 24].